Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold on Wegovy is reported by some people, but it is not listed as a direct pharmacological effect of semaglutide on the body's temperature regulation. The more likely explanation is indirect: as you eat less and lose weight, your body produces less heat, and your metabolism adjusts. This page separates that well-evidenced mechanism from the rarer possibilities, so you know what to watch for and when to mention it to your prescriber. Wegovy is a prescription-only medicine; a qualified clinician decides whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The idea that semaglutide itself lowers your body temperature is a common assumption worth clearing up early. Wegovy works as a GLP-1 receptor agonist, it slows gastric emptying and acts on appetite centres in the brain, reducing hunger and calorie intake over time. If you have been wondering whether Wegovy makes you cold through some direct mechanism, the answer is that there is no established pathway by which it instructs your body to run colder, and the NHS medicines page for semaglutide does not list feeling cold as a recognised side effect of the drug itself.
That distinction matters. It means that if you are feeling cold regularly after starting Wegovy, the likely explanation sits one step removed from the medicine (in what the medicine does to your eating and your weight) rather than in semaglutide's direct chemistry. Understanding that helps you respond appropriately rather than assuming the treatment is doing something harmful.
That said, feelings people experience on any treatment are real even when the cause is indirect. Dismissing the symptom doesn't help; understanding it does. Our broader look at the side effects people associate with Wegovy covers the full picture, including what is well-documented and what is still being studied.
Human body heat is largely a by-product of metabolism. When you eat significantly less, your body produces fewer calories to burn, and core heat generation tends to drop a little with it. This is a well-established physiological response to calorie restriction and is not unique to GLP-1 medicines, it happens on any diet that produces meaningful weight loss.
As people lose fat tissue, they also lose a layer of insulation. Fat stores sit just below the skin and act as a thermal buffer against ambient temperature. Losing a stone or more over several months genuinely changes how exposed you feel on a cold morning. You might notice it standing at the kitchen window waiting for the kettle, where you'd barely have registered it before. This is normal biology, not a warning sign.
There is also a separate question about muscle. Rapid weight loss without enough protein or resistance activity can lead to some loss of lean mass, and muscle is a significant generator of body heat. Maintaining protein intake and keeping active throughout treatment is recommended for this reason, among others. If you are unsure what your intake should look like while on Wegovy, that is a conversation for your prescriber or a registered dietitian, not something to calibrate from a general article.
For context on how long treatment typically continues and what the overall clinical picture looks like, our page on Wegovy lifespan covers the mechanism and trial evidence in full.
Occasional chilliness is one thing. Persistent, unexplained coldness (especially if it comes with unusual fatigue, dry skin, hair thinning, or constipation that feels different from the GI effects expected in the first weeks of treatment) can sometimes suggest thyroid function changes. Hypothyroidism and GLP-1 treatment are not directly linked by current evidence, but thyroid conditions are common in the general population and can emerge or worsen for unrelated reasons. Starting a new medicine is often the moment people pay closer attention to their bodies, which is why symptoms that were already present sometimes come to light.
Iron-deficiency anaemia is another possibility worth considering, particularly if your appetite has dropped sharply and your diet has become less varied. Anaemia commonly causes cold hands and feet, fatigue and pallor, and is straightforward to test for via a blood panel. This is not a reason to panic, but it is a reason to mention persistent coldness to your GP rather than waiting it out.
The MHRA's Yellow Card scheme allows patients to report any unexpected effects they experience on a medicine; this includes symptoms not currently listed on the patient leaflet. Reporting helps build the evidence base as Wegovy's use in the wider population continues to grow.
Practically, the first step is to assess whether the coldness appeared alongside noticeable weight loss and reduced appetite, or whether it arrived independently of any change in those areas. If it tracks closely with eating less and losing weight, the indirect metabolic explanation is the most plausible one, and improving protein intake and physical activity often helps over time.
If coldness feels disproportionate, has started alongside other new symptoms, or is affecting your quality of life, raise it at your next clinical review. Do not adjust your dose or stop treatment on your own, those are prescriber decisions, guided by your full clinical picture. Our dedicated page on the sensation of feeling cold while on semaglutide goes into further practical detail.
For anyone considering Wegovy and weighing up what the experience is actually like day to day, our patient-experience guide to feeling cold on Wegovy brings together what people commonly report. And if you are thinking about the storage side of things (the medicine itself does need refrigerating) how cold Wegovy needs to be kept is a separate, practical question with a straightforward answer.
Wegovy is a prescription-only medicine. If you are ready to explore whether it might be clinically suitable for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.